ARCHIVES

Patient Groups Are Focus of New Alliances In a Shift of Cancer Advocacy Agenda

This article is from The Cancer Letter archive.

Vol. 22 No. 22 | May 31, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia Still In Running As Comprehensive Center In ’78; Illinois Withdraws Application

June 24, 1977

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

Reports Propose Stricter Rules To Protect Research Participants

October 11, 2002

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

November 1, 1985